The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

INTRODUCTION: Although patient-reported outcome (PRO) measures provide important information beyond clinical data, studies that assess the PROs of type 2 diabetes mellitus (T2DM) patients initiating injectable glucose-lowering medications in routine clinical practice are limited. We describe the per...

Descripción completa

Detalles Bibliográficos
Autores principales: Boye, Kristina S., Sapin, Hélène, García-Pérez, Luis-Emilio, Rosilio, Myriam, Orsini Federici, Marco, Heitmann, Elke, Jung, Heike, Aigner, Ulrich, Guerci, Bruno, Giorgino, Francesco, Norrbacka, Kirsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509014/
https://www.ncbi.nlm.nih.gov/pubmed/32880876
http://dx.doi.org/10.1007/s13300-020-00908-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509014/
https://www.ncbi.nlm.nih.gov/pubmed/32880876
http://dx.doi.org/10.1007/s13300-020-00908-9

Ejemplares similares